Mathematical models for human cancer incidence rates

Demographic Research

Volumn 12, Issue , 2005, Pages 237-272

  Arbeev, Konstantin G ^a,b   Ukraintseva, Svetlana V ^a   Arbeeva, Lyubov S ^b   Yashin, Anatoli I ^a,c  

^a DUKE UNIVERSITY   (United States)

^b ULYANOVSK STATE UNIVERSITY   (Russian Federation)

^c MAX PLANCK INSTITUTE FOR DEMOGRAPHIC RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 26044469066     PISSN: 14359871     EISSN: 14359871     Source Type: Journal    
DOI: 10.4054/DemRes.2005.12.10     Document Type: Article

References (49)

1. Anstey K.J., Lord S.R., Smith G.A. (1996). "Measuring human functional age: a review of empirical findings". Exp. Aging Res., 22, 3: 245-266.
2. Armitage P., Doll R. (1954). "The age distribution of cancer and a multistage theory of carcinogenesis". Br. J. Cancer, 8: 1-12.
3. Benson D., Mitchell N., Dix D. (1996). "On the role of aging in carcinogenesis". Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 356, 2: 209-216.
4. Cheron G., Desmedt J.E. (1980). "Peripheral and central somatosensory pathways and evoked cerebral potentials during aging". Rev. Electroencephalogr. Neurophysiol. Clin., 10: 146-152.
5. Dean W. (1988). Biological Aging Measurement. Los Angeles: The Center Biogerontol.
6. Dix D. (1989). "The role of aging in cancer incidence: an epidemiological study". J. Gerontol., 44, 6: 10-18.
7. Grove G., Kilgman A. (1983). "Age-associated changes in human epidermal cell renewal". J. Geront., 38: 137-142.
8. Guyton A.C., Hall J.E. (1996). Textbook of Medical Physiology. Philadelphia: W.B. Saunders Co.
9. Health US, DHHS Publications, 1997-2000.
10. IARC (1965). Cancer Incidence in Five Continents. Volume I. Lyon: International Agency for Research on Cancer.
11. IARC (1970). Cancer Incidence in Five Continents. Volume II. Lyon: International Agency for Research on Cancer.
12. IARC (1976). Cancer Incidence in Five Continents. Volume III. Lyon: IARC Sci Publ, 15.
13. IARC (1982). Cancer Incidence in Five Continents. Volume IV. Lyon: IARC Sci Publ, 42.
14. IARC (1987). Cancer Incidence in Five Continents. Volume V. Lyon: IARC Sci Publ, 88.
15. IARC (1992). Cancer Incidence in Five Continents. Volume VI. Lyon: IARC Sci Publ, 120.
16. IARC (1997). Cancer Incidence in Five Continents. Volume VII. Lyon: IARC Sci Publ, 143.
17. Keogh E., Walsh R. (1965). "Rate of graying of human hair". Nature, 207: 877-878.
18. Krtolica A., Campisi J. (2002). "Cancer and aging: a model for the cancer promoting effects of the aging stroma". Int. J. Biochem. Cell. Biol., 34, 11: 1401.
19. Kuramoto K., Matsushita S., Esaki Y., Shimada H. (1993). "Prevalence, rate of correct clinical diagnosis and mortality of cancer in 4,894 elderly autopsy cases". Nippon Ronen Igakkai Zasshi., 30, 1: 35-40, in Japanese.
20. McClearn G.E. (1997). "Bio-markers of age and aging". Exp. Gerontol., 32, 1-2: 87-94.
21. Moolgavkar S.H., Venzon D.J. (1979). "Two-event models for carcinogenesis: incidence curves for childhood and adult tumors". Math. Biosci., 47: 55-77.
22. Moolgavkar S.H., Knudson A.G. (1981). "Mutation and cancer: a model for human carcinogenesis". J. Natl. Cancer Inst., 66: 1037-1052.
23. Moolgavkar S.H., Luebeck E.G. (1990). "Two-event model for carcinogenesis: biological, mathematical and statistical considerations". Risk Anal., 10: 323-341.
24. Moolgavkar S.H., Krewski, D., Zeise L., Cardis E., Møller H. (1999). Quantitative Estimation and Prediction of Human Cancer Risks. Lyon: IARC Sci Publ.
25. Nakamura E., Lane M., Roth G., Ingram D. (1998). "A strategy for identifying biomarkers of aging". Exp. Gerontology, 33: 4.
26. Peto R., Roe F.J., Lee P.N., Levy L., Clack J. (1975). "Cancer and ageing in mice and men." Br. J. Cancer, 32, 4: 411-426.
27. Peto R., Parish S.E., Gray R.G. (1985). "There is no such thing as ageing, and cancer is not related to it". IARC Sci Publ, 58: 43-53.
28. Pompei F., Polkanov M., Wilson R. (2001). "Age distribution of cancer in mice: the incidence turnover at old age." Toxicol Ind Health, 17, 1: 7-16.
29. Rainsford J., Cohen P., Dix D. (1985). "On the role of aging in cancer incidence: analysis of the lung cancer data". Anticancer Res, 5, 4: 427-430.
30. Remmen H., Ward W., Sabia R., Richardson A. (1995). "Gene expression and protein degradation". In: Masoro, E., editor. Handbook of Physiology: Section 11, Aging. New York: Oxford Univ. Press: 171.
31. Riggs J.E., Millecchia R.J. (1992). "Using the Gompertz-Strehler Model of Aging and Mortality to Explain Mortality Trends in Industrialized Countries". Mechanisms of Aging and Development, 65: 217-228.
32. Riggs J.E., Hobbs G.R. (1998). "Nonrandom sequence of slope-intercept estimates in longitudinal Gompertzian analysis suggests biological relevance". Mechanisms of Aging and Development, 100: 269-275.
33. Robertson C., Gandini S., Boyle P. (1999). "Age-Period-Cohort Models: A Comparative Study of Available Methodologies". J. Clin Epidemiol, 52, 6: 569-583.
34. Rubin H. (1997). "Cell aging in vivo and in vitro". Mech. Aging and Dev., 98: 1-35.
35. Smith D. (1996). "Cancer mortality at very old ages". Cancer, 77, 7: 1367-1372.
36. Smith D. (1999). "Resistance to causes of death: a study of cancer mortality resistance in the oldest old". In: Robine J-M et. al. (Eds). The Paradoxes of Longevity. Springer-Verlag: 61-71.
37. Sohal R., Weindruch R. (1996). "Oxidative stress, caloric restriction, and aging". Science, 273: 59-63.
38. Stanta G., Campagner L., Cavallieri F., Giarelli L. (1997). "Cancer of the oldest old. What we have learned from autopsy studies." Clin Geriatr Med, 13, 1: 55-68.
39. Strehler B. (1962). Time, Cells, and Aging. London: Academic Press.
40. Strehler B.L., Mildvan A.S. (1960). "General theory of mortality and aging". Science, 132: 14-21.
41. Ukraintseva S.V., Yashin A.I. (2001). "How individual aging may influence human morbidity and mortality patterns". Mech. Aging and Dev., 122: 1447-1460.
42. Ukraintseva S.V., Yashin A.I. (2003). "Individual aging and cancer risk: How are they related?" Demographic Research, 9, 8: 163-196.
43. Van Leeuwen I.M.M., Zonneweld C. (2001). "From exposure to effect: a comparison of modeling approaches to chemical carcinogenesis". Mutation Research, 489: 17-45.
44. Vaupel J.W., Manton K.G., Stallard E. (1979). "The impact of heterogeneity in individual frailty on the dynamics of mortality". Demography, 16: 439-454.
45. Vaupel J.W., Yashin A.I. (1985). "Heterogeneity's ruses: some surprising effects of selection on population dynamics". The American Statistician, 39, 3: 176-184.
46. Vaupel J.W., Yashin A.I. (1988). "Cancer Rates over Age, Time, and Place: Insights from Stochastic Models of Heterogeneous Populations." WP #88-01-1 of the Center for Population Analysis and Policy, University of Minnesota, and MPIDR Working Paper WP 1999-006.
47. Volpe E.W., Dix D. (1986). "On the role of aging in cancer incidence: cohort analyses of the lung cancer data". Anticancer Res, 6, 6: 1417-1420.
48. Yakovlev A.Yu., Asselain B., Bardou V.-J., Fourquet A., Hoang T., Rochefodiere A., Tsodikov A.D. (1993). "A simple stochastic model of tumor recurrence and its application to data on pre-menopausal breast cancer". In: Asselain B., Boniface M., Duby C., Lopez C., Masson J.P., Tranchefort J., editors. Biometrie et Analyse de Donnees Spatio-Temporelles No 12. Rennes: Societe Francaise de Biometrie, ENSA Rennes, France: 66-82.
49. Yakovlev A.Yu., Tsodikov A.D. (1996). Stochastic Models of Tumor Latency and their Bio-statistical Applications. Singapore: World Scientific.